Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization

  • Antra Zeltina
  • , Stefanie A. Krumm
  • , Mehmet Sahin
  • , Weston B. Struwe
  • , Karl Harlos
  • , Jack H. Nunberg
  • , Max Crispin
  • , Daniel D. Pinschewer
  • , Katie J. Doores
  • , Thomas A. Bowden

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Transmission of hemorrhagic fever New World arenaviruses from their rodent reservoirs to human populations poses substantial public health and economic dangers. These zoonotic events are enabled by the specific interaction between the New World arenaviral attachment glycoprotein, GP1, and cell surface human transferrin receptor (hTfR1). Here, we present the structural basis for how a mouse-derived neutralizing antibody (nAb), OD01, disrupts this interaction by targeting the receptor-binding surface of the GP1 glycoprotein from Junín virus (JUNV), a hemorrhagic fever arenavirus endemic in central Argentina. Comparison of our structure with that of a previously reported nAb complex (JUNV GP1-GD01) reveals largely overlapping epitopes but highly distinct antibody-binding modes. Despite differences in GP1 recognition, we find that both antibodies present a key tyrosine residue, albeit on different chains, that inserts into a central pocket on JUNV GP1 and effectively mimics the contacts made by the host TfR1. These data provide a molecular-level description of how antibodies derived from different germline origins arrive at equivalent immunological solutions to virus neutralization.

Original languageEnglish
Pages (from-to)7031-7036
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number27
DOIs
StatePublished - Jul 3 2017

Funding

A.Z. is supported by the European Union Horizon 2020 Marie Curie Fellowship (658363); T.A.B. and K.J.D. are supported by the Medical Research Council (MR/J007897/1, MR/L009528/1, MR/K024426/1, and MR/N002091/1); D.D.P. is supported by the Swiss National Science Foundation (Grant 310030-149340/1); work in the M.C. laboratory is supported by the International AIDS Vaccine Initiative (IAVI), an IAVI Neutralizing Antibody Center Collaboration for AIDS Vaccine Discovery grant, and the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (1UM1AI100663); J.H.N. is supported by NIH Grant R15 AI119803; and The Wellcome Trust Centre for Human Genetics is supported by Wellcome Trust Centre Grant 203141/Z/16/Z.

FundersFunder number
1UM1AI100663
203141/Z/16/Z.
R15 AI119803
UM1AI100663
International AIDS Vaccine Initiative
Wellcome Trust
Medical Research CouncilMR/J007897/1, MR/L009528/1, MR/K024426/1, MR/N002091/1
310030-149340/1
658363

    Keywords

    • Antibody response
    • Arenavirus
    • Glycoprotein
    • Hemorrhagic fever
    • Structure

    Fingerprint

    Dive into the research topics of 'Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization'. Together they form a unique fingerprint.

    Cite this